BlackRock’s Orchestra BioMed OBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.83M Sell
681,349
-1,264,307
-65% -$3.39M ﹤0.01% 4012
2025
Q1
$8.33M Sell
1,945,656
-33,174
-2% -$142K ﹤0.01% 3371
2024
Q4
$7.92M Buy
1,978,830
+36,439
+2% +$146K ﹤0.01% 3496
2024
Q3
$9.98M Buy
1,942,391
+77,418
+4% +$398K ﹤0.01% 3365
2024
Q2
$15.2M Buy
1,864,973
+423,784
+29% +$3.45M ﹤0.01% 3098
2024
Q1
$7.6M Sell
1,441,189
-27,579
-2% -$145K ﹤0.01% 3437
2023
Q4
$13.4M Buy
1,468,768
+138,854
+10% +$1.27M ﹤0.01% 3178
2023
Q3
$11.6M Buy
1,329,914
+474,347
+55% +$4.14M ﹤0.01% 3198
2023
Q2
$5.99M Buy
855,567
+150,892
+21% +$1.06M ﹤0.01% 3575
2023
Q1
$13.8M Sell
704,675
-85,761
-11% -$1.68M ﹤0.01% 3088
2022
Q4
$7.89M Hold
790,436
﹤0.01% 3438
2022
Q3
$7.83M Sell
790,436
-4,704
-0.6% -$46.6K ﹤0.01% 3482
2022
Q2
$7.92M Hold
795,140
﹤0.01% 3545
2022
Q1
$7.88M Sell
795,140
-2,208
-0.3% -$21.9K ﹤0.01% 3635
2021
Q4
$8.04M Hold
797,348
﹤0.01% 3726
2021
Q3
$7.89M Hold
797,348
﹤0.01% 3726
2021
Q2
$8.13M Sell
797,348
-2,652
-0.3% -$27.1K ﹤0.01% 3653
2021
Q1
$8.95M Hold
800,000
﹤0.01% 3582
2020
Q4
$10.2M Hold
800,000
﹤0.01% 3279
2020
Q3
$8.8M Buy
+800,000
New +$8.8M ﹤0.01% 3212